An endoplasmic reticulum and lipid droplets dual-localized strategy to develop small molecular photosensitizers that induce ferroptosis during photodynamic therapy
- PMID: 39854940
- DOI: 10.1016/j.ejmech.2025.117306
An endoplasmic reticulum and lipid droplets dual-localized strategy to develop small molecular photosensitizers that induce ferroptosis during photodynamic therapy
Abstract
Organelle-localized photosensitizers have been well-developed to enhance the photodynamic therapy (PDT) efficacy through triggering given cell death. The endoplasmic reticulum (ER) and lipid droplets (LDs) are two key organelles mutually regulating ferroptosis. Thus, in this study, small molecular photosensitizer CAR PSs were developed through fragment integration strategy and the heavy-atom modification. It was showed that the integration strategy did not affect the organelle localization and CAR PSs successfully achieved ER/LDs dual location. Besides, the heavy-atom modification help CAR PSs display good ROS generation efficiency. Importantly, ER/LDs dual-localized CAR PSs exhibited superior photo-toxicity and lower dark-toxicity against multiple breast cancer cell lines than the only ER-targeting Ce6, which further explained the superposition effect of dual organelle targeting. Preliminary studies revealed that CAR PSs induced enhanced ferroptosis via simultaneously triggering the ER stress and lipid peroxidation during PDT. Moreover, CAR-2 demonstrated significant in vivo PDT activity to suppress the tumor growth in 4T1 tumor bearing mice. These findings not only provide a promising photosensitizer CAR-2 exerting excellent in vitro and in vivo PDT effect through stimulating ferroptosis, but also propose a design strategy for the development of ER/LDs dual localized PSs.
Keywords: BODIPY-Based photosensitizer; Dual localization; Endoplasmic reticulum; Ferroptosis; Lipid droplets.
Copyright © 2025 Elsevier Masson SAS. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Coumarin-Quinazolinone based photosensitizers: Mitochondria and endoplasmic reticulum targeting for enhanced phototherapy via different cell death pathways.Eur J Med Chem. 2024 Dec 15;280:116990. doi: 10.1016/j.ejmech.2024.116990. Epub 2024 Oct 19. Eur J Med Chem. 2024. PMID: 39442335
-
An epidermal growth factor receptor-targeted and endoplasmic reticulum-localized organic photosensitizer toward photodynamic anticancer therapy.Eur J Med Chem. 2019 Nov 15;182:111625. doi: 10.1016/j.ejmech.2019.111625. Epub 2019 Aug 14. Eur J Med Chem. 2019. PMID: 31442683
-
Facile synthesis and biological evaluation of [a]-benzannulated BODIPY derivatives as novel heavy-atom-free photosensitizers for photodynamic anticancer therapy.Bioorg Chem. 2025 Aug;163:108766. doi: 10.1016/j.bioorg.2025.108766. Epub 2025 Jul 18. Bioorg Chem. 2025. PMID: 40706538
-
Organelle-targeted small molecular photosensitizers for enhanced photodynamic therapy: a minireview for recent advances and potential applications.Chem Commun (Camb). 2025 May 13;61(40):7236-7252. doi: 10.1039/d5cc01642h. Chem Commun (Camb). 2025. PMID: 40289926 Review.
-
Ferroptosis: A novel cell death modality as a synergistic therapeutic strategy with photodynamic therapy.Photodiagnosis Photodyn Ther. 2025 Feb;51:104463. doi: 10.1016/j.pdpdt.2024.104463. Epub 2024 Dec 28. Photodiagnosis Photodyn Ther. 2025. PMID: 39736368 Review.
Cited by
-
A dual-type I/II NIR photosensitizer for effective cancer photodynamic therapy with enhanced ROS generation.RSC Adv. 2025 Aug 18;15(35):28889-28896. doi: 10.1039/d5ra05267j. eCollection 2025 Aug 11. RSC Adv. 2025. PMID: 40861992 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources